These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 17637742)
1. Characterization of mammary tumors from Brg1 heterozygous mice. Bultman SJ; Herschkowitz JI; Godfrey V; Gebuhr TC; Yaniv M; Perou CM; Magnuson T Oncogene; 2008 Jan; 27(4):460-8. PubMed ID: 17637742 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831 [TBL] [Abstract][Full Text] [Related]
3. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer. Medina PP; Sanchez-Cespedes M Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052 [TBL] [Abstract][Full Text] [Related]
4. The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner. Serber DW; Rogala A; Makarem M; Rosson GB; Simin K; Godfrey V; Van Dyke T; Eaves CJ; Bultman SJ PLoS One; 2012; 7(2):e31346. PubMed ID: 22363625 [TBL] [Abstract][Full Text] [Related]
5. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494 [TBL] [Abstract][Full Text] [Related]
6. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584 [TBL] [Abstract][Full Text] [Related]
7. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839 [TBL] [Abstract][Full Text] [Related]
8. Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features. Matsubara D; Kishaba Y; Ishikawa S; Sakatani T; Oguni S; Tamura T; Hoshino H; Sugiyama Y; Endo S; Murakami Y; Aburatani H; Fukayama M; Niki T Cancer Sci; 2013 Feb; 104(2):266-73. PubMed ID: 23163725 [TBL] [Abstract][Full Text] [Related]
9. BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility. Willis MS; Holley DW; Wang Z; Chen X; Quintana M; Jensen BC; Tannu M; Parker J; Jeyaraj D; Jain MK; Wolfram JA; Lee HG; Bultman SJ J Mol Cell Cardiol; 2017 Apr; 105():99-109. PubMed ID: 28232072 [TBL] [Abstract][Full Text] [Related]
10. Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. Smith-Roe SL; Bultman SJ Mamm Genome; 2013 Feb; 24(1-2):21-9. PubMed ID: 23076393 [TBL] [Abstract][Full Text] [Related]
11. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Bultman S; Gebuhr T; Yee D; La Mantia C; Nicholson J; Gilliam A; Randazzo F; Metzger D; Chambon P; Crabtree G; Magnuson T Mol Cell; 2000 Dec; 6(6):1287-95. PubMed ID: 11163203 [TBL] [Abstract][Full Text] [Related]
12. Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation. Chai J; Lu X; Godfrey V; Fletcher C; Roberts CW; Van Dyke T; Weissman BE Cancer Res; 2007 Apr; 67(7):3002-9. PubMed ID: 17409406 [TBL] [Abstract][Full Text] [Related]
14. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541 [TBL] [Abstract][Full Text] [Related]
15. When the SWI/SNF complex remodels...the cell cycle. Muchardt C; Yaniv M Oncogene; 2001 May; 20(24):3067-75. PubMed ID: 11420722 [TBL] [Abstract][Full Text] [Related]
17. SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice. Wiley MM; Muthukumar V; Griffin TM; Griffin CT J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904594 [TBL] [Abstract][Full Text] [Related]
18. Targeted knockout of BRG1 potentiates lung cancer development. Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D Cancer Res; 2008 May; 68(10):3689-96. PubMed ID: 18483251 [TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alterations of BRG1 promote oral cancer development. Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241 [TBL] [Abstract][Full Text] [Related]
20. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]